AWH | tickerfilter.com

Fundamental analysis

35%

Profitability 43%

Dept financing 25%

Liquidity 30%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

-25.45%

3 Months

-79.50%

6 Months

-91.28%

1 Year

-97.54%

2 Year

-98.33%

Key data

Stock price

$0.08

P/E Ratio

0.00

DAY RANGE

$0.08 - $0.09

EPS

-$1.00

52 WEEK RANGE

$0.08 - $3.38

52 WEEK CHANGE

-$97.54

MARKET CAP

11.750 M

YIELD

N/A

SHARES OUTSTANDING

16.063 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

-0.97

PUBLIC FLOAT

AVERAGE 10 VOLUME

N/A

AVERAGE 30 VOLUME

$1,107,731

Company detail

CEO: Nicole Sandford
Region: US
Website: aspirawh.com
Employees: 110
IPO year: 2000

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Aspira Women's Health Inc. engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVAInherit tests to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of Gynecologic cancer.

AWH - Aspira Women's Health Inc.